To confirm whether IGF2BP3 is an oncogenic factor in GC, we established stable IGF2BP3-knockdown GC cell lines (MKN-45 and AGS) using shRNAs (Fig. 2A). This evidence concerns the gene IGF2BP3 and gastric cancer.